A Cohort Study of Hydatidiform Mole

Launched by WOMEN'S HOSPITAL SCHOOL OF MEDICINE ZHEJIANG UNIVERSITY · Nov 23, 2022

Keywords

ClinConnect Summary

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
• • 2. Age 13-55 years old;
• • 3. Obtain informed consent and sign an informed consent form
• Exclusion Criteria:
• • 1. Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
• • 2. No histopathology diagnosis;
• • 3. Patients with other malignancies

Trial Officials